Epitope-Based Peptide Vaccine against Bombali Ebolavirus Viral Protein 40: An Immunoinformatics Combined with Molecular Docking Studies

Abstract

BackgroundBombali Ebolavirus is RNA viruses belong to the Filoviridae family. They are causing lethal hemorrhagic fever with high mortality rate. Despite having available molecular knowledge of this virus, no approved vaccine or antiviral drugs have been developed yet for the eradication of Bombali Ebolavirus infections in humans.Objectivethe present study described a multi epitope-based peptide vaccine against Bombali Ebolavirus matrix protein VP40, using several immunoinformatics tools.Materials and MethodsThe six strains of Ebolavirus were retrieved from NCBI and Uniprot databases and submitted to VaxiJen to identify the most antigenic protein among all. Then PSIPRED, SOPMA, QMEAN, and PROCHECK tools were used to check the protein quality. T-cell prediction, population coverage, and molecular docking analysis were achieved to select peptides containing multiple Bombali VP40 epitopes showing interaction with multiple HLA molecules for expected immune response across the world.ResultBombali Ebola (YP_009513276.1) was found to be the most antigenic protein among all. Which it has been used in all required analysis. For T cell three epitopes showed high affinity to MHC class I (YSFDSTTAA, VQLPQYFTF, and MVNVISGPK) and high population coverage against Africa and the world. Furthermore in MHC class II, six promising epitopes that associated with most common MHC class II alleles.ConclusionThe above result conclude that, these peptides capable of provoking T-cell response and being interacted with a wide range of HLA molecules have a strong potential to be a vaccine against Bombali Ebolavirus.

Immunoinformatic Guided Rational Design of a Next Generation Multi Epitope Based Peptide Vaccine against Marburg Virus Disease Combined with Molecular Docking Studies

“…Immunoinformatics studies to the development of effective vaccines against a variety of microorganisms, particularly viruses, are becoming more widely accepted as a first stage of vaccine design. Recently, immunoinformatics-guided methods have been used in the development of several multi epitope-based peptide vaccine for many pathogens [10,[29][30][31][32][33][34][35][36].…”

Exploring B and T-cell epitopes for constructing a Novel Multiepitope vaccine to combat emerging Monkeypox infection: A Reverse Vaccinology approach

“…This approach is highly acceptable in the present era to avoid extra costs, resources and formulate effective target-specific therapeutics in a timely manner. A much interest has been developed and immunoinformatics-guided techniques has been used to formulate epitope-based subunit vaccines [34][35][36].…”

Smart therapies against global pandemics: A potential of short peptides

“…We can also mention the multi-epitope peptide vaccine against antibiotic resistance (Ismail et al, 2021), or the nanodiamond-peptide-based vaccine as an 'emergency' panvaccine against newly emerging viruses or bacteria (Billy et al, 2021). Vaccinomics approach and advanced bioinformatics tools are helpful in design of effective vaccines against Marburg (Pervin and Oany, 2021), Nipah (Soltan et al, 2021), Zika (Antonelli et al, 2022), Ebola (Nandy et al, 2018;Mustafa et al, 2021), Lassa (Omoniyi et al, 2021), rift valley fever (Fatima et al, 2022) viruses as well as malaria (Aza-Conde et al, 2021) caused by parasites-potential agents of pandemics, including bioterrorism. The 'smart' vaccine strategy uses advanced machine learning to peptide-based epitope mapping and it precisely predicts the binding between viral peptides and human proteins, leading to an increase in the speed of the design and development of broad spectrum ('universal') vaccines (Du et al, 2022).…”